Mild Cognitive Impairment Clinical Trial
Official title:
Effects of Thai Dance With Twenty-five Squares on Cerebrovascular and Cognitive Function in Elderly With Mild Cognitive Impairment
The objective of this study was to determine the effects of Thai dance with twenty-five squares on cerebrovascular and cognitive function in elderly with mild cognitive impairment
Status | Recruiting |
Enrollment | 40 |
Est. completion date | June 1, 2024 |
Est. primary completion date | May 15, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 79 Years |
Eligibility | Inclusion Criteria: - Elderly males and females aged 60-79 years who can lead normal daily lives. Individuals with mild cognitive impairment identified through the Montreal Cognitive Assessment (MoCA) with a score in the range of 17 - 25. - Must be able to listen, speak, read, write, and understand the Thai language. - Should not have diseases or abnormalities such as heart disease, eye complications caused by diabetes, uncontrolled high blood pressure, kidney complications caused by diabetes, and stroke. - Must not have other respiratory diseases such as tuberculosis (Tuberculosis), asthma (Asthma), lung cancer (Lung cancer), emphysema (Emphysema), chronic obstructive pulmonary disease (COPD), etc. - Must be a person not at risk of falling, determined through a test of the ability to walk and turn 3 meters within a time period of 7 - 15 seconds. - Must not have received medication to treat dementia. - Should not have received exercise training for more than 20 minutes at a time, 3 days/week, or more in the past 6 months before participating in the research. - Should not have symptoms of mental disorders such as schizophrenia, bipolar disorder, or depression. - Should have passed the pre-exercise readiness assessment (PAR-Q). - Must be willing to participate in the research and sign the consent form to take part in the study. Exclusion Criteria: - A force majeure event, such as illness, that prevents participation in the research. - Participation in less than 80% of the research sessions (must participate 29 times out of 36 times). - Unwillingness to continue participating in the research. |
Country | Name | City | State |
---|---|---|---|
Thailand | Wannaporn Tongtako | Bangkok | |
Thailand | Faculty of Sports Science, Chulalongkorn University | Pathum Wan | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Chulalongkorn University |
Thailand,
Akazawa N, Tanahashi K, Kosaki K, Ra SG, Matsubara T, Choi Y, Zempo-Miyaki A, Maeda S. Aerobic exercise training enhances cerebrovascular pulsatility response to acute aerobic exercise in older adults. Physiol Rep. 2018 Apr;6(8):e13681. doi: 10.14814/phy2 — View Citation
Bherer L. Cognitive plasticity in older adults: effects of cognitive training and physical exercise. Ann N Y Acad Sci. 2015 Mar;1337:1-6. doi: 10.1111/nyas.12682. — View Citation
Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc. 2010 Feb;58(2):248-55. doi: 10.1111/j.1532-5415.2009.02671.x. Epub 2010 Ja — View Citation
Miller SM, Taylor-Piliae RE. Effects of Tai Chi on cognitive function in community-dwelling older adults: a review. Geriatr Nurs. 2014 Jan-Feb;35(1):9-19. doi: 10.1016/j.gerinurse.2013.10.013. Epub 2013 Oct 24. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cerebrovascular reactivity | Cerebrovascular reactivity is a test that assesses the response of cerebral blood vessels to carbon dioxide. This test analyzes the ability of cerebral blood vessels to contract and expand. Using an ultrasound machine and a probe with a frequency of 5 to 1 MHz, the partial pressure of CO2 is altered, and Cerebral Blood Flow Velocity (CBFV) is measured in the left middle cerebral artery at an examination depth of 30-65 mm. The variables used for analysis include Time-Averaged Peak Velocity (TAPV), Peak Systolic Velocity; PSV, End Diastolic Velocity; EDV, and Cerebral Blood Vessel Resistance (Pulsatility Index; PI). | Change from baseline Cerebrovascular reactivity at 12 weeks. | |
Primary | Intima-Media Thickness (IMT) test | Intima-Media Thickness (IMT) is a test conducted on the carotid artery on the side of the neck. Using an ultrasound machine (Philips, EPIQ 5G, USA), the thickness of the carotid artery walls was measured 1-2 cm away from the carotid bulb. Participants had their necks tilted 45 degrees. The artery walls were measured and then analyzed for thickness using the QLAB program. | Change from baseline Intima-Media Thickness (IMT) at 12 weeks. | |
Primary | Brachial-ankle pulse wave velocity (baPWV) | Brachial-ankle pulse wave velocity (baPWV) is utilized to indicate the arterial stiffness. This noninvasive test measure the time difference in blood pumping (brachial-ankle time delay) between the brachial artery and the posterior tibial artery. The length between both measurement points is then measured, and the pulse pressure wave between the upper arm and ankle is calculated (Brachial-ankle pulse wave velocity: baPWV), with the participant lying on their back on a bed. Next, both wrists and the left upper chest are cleaned with alcohol. The researcher then attaches cuffs to both the participants' arms and ankles, and electrodes of the device for measuring electrocardiograms are attached to the wrists. Additionally, cardiac sound waves (PCG) are placed on the left side near the sternum (Sternal notch). | Change from baseline Brachial-ankle pulse wave velocity (baPWV) at 12 weeks. | |
Primary | Brain oxygen saturation levels | Brain oxygen saturation levels are assessed in the frontal lobe area using an oxygen saturation level meter (Universal Oximetry System), measured in percentage units. The evaluation is performed with a brain oxygen saturation level assessment device, specifically the SenSmart® Model X-100 (SenSmart® Model X-100, USA). | Change from baseline Brain oxygen saturation levels at 12 weeks. | |
Primary | The Monreal Cognitive Assessment (MoCA-T) | The Monreal Cognitive Assessment, known as MoCA-T, is a questionnaire comprising 11 topics with a maximum score of 30 points. It serves as a comprehensive tool for assessing various aspects of cognitive intelligence in various areas, including management, naming, concentration, language use, and abstract thinking. | Change from baseline MoCA-T scores at 12 weeks. | |
Primary | The Mini-Mental State Examination Thai (MMSE-T) | The Mini-Mental State Examination Thai (MMSE-T) is a preliminary brain condition test that comprises 11 topics with a maximum score of 30 points. This basic brain state test is utilized to assess various aspects of cognition, including awareness of surrounding conditions, perception of time, spatial orientation, concentration and calculation, language use, and repetition. | Change from baseline MMSE-T scores at 12 weeks. | |
Primary | The Trail Making Test B Thai modified (TMT-B) | The Trail Making Test B Thai modified (TMT-B) is a subtest in the Halstead-Reitan Neuropsychological test, adapted into Thai. The criteria for normalcy is set at no more than 89 seconds for individuals aged 60 years and over. The test includes numbers 1-13 and month abbreviations in Thai (Jan. - Dec.), totaling 25 characters, which consist of numbers and/or letters. They are arranged in a distributed manner, and when connecting lines are drawn, they will not intersect. The TMT-B serves as an assessment of cognitive ability, focusing on concentration and management. | Change from baseline TMT-B testing time at 12 weeks. | |
Secondary | Pulmonary function (Forced vital capacity; FVC) | The participants were instructed to sit on a chair and wear a nose clip. The researcher provided them with a detailed set of instructions to ensure they performed the maneuver correctly according to guidelines of the American Thoracic Society (ATS). Prior to demonstrating forced inspiration and expiration, the participants were asked to perform three cycles of slow normal breathing as part of the FVC maneuver. FVC will be reported in liter (L). | Change from baseline FVC at 12 weeks. | |
Secondary | Pulmonary function (Forced Expiratory Volume in one second; FEV1) | The participants were instructed to sit on a chair and wear a nose clip. The researcher provided them with a detailed set of instructions to ensure they performed the maneuver correctly according to guidelines of the American Thoracic Society (ATS). Prior to demonstrating forced inspiration and expiration, the participants were asked to perform three cycles of slow normal breathing as part of the FVC maneuver. FEV1 (L) will be reported in liter (L). | Change from baseline FEV1 at 12 weeks. | |
Secondary | Pulmonary function (The ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs; FEV1/FVC) | The participants were instructed to sit on a chair and wear a nose clip. The researcher provided them with a detailed set of instructions to ensure they performed the maneuver correctly according to guidelines of the American Thoracic Society (ATS). Prior to demonstrating forced inspiration and expiration, the participants were asked to perform three cycles of slow normal breathing as part of the FVC maneuver. FEV1/FVC will be reported in percent (%). | Change from baseline FEV1/FVC at 12 weeks. | |
Secondary | Pulmonary function (Maximal voluntary ventilation; MVV) | The participants were instructed to sit on a chair and wear a nose clip. The researcher provided them with a detailed set of instructions to ensure they performed the maneuver correctly according to guidelines of the American Thoracic Society (ATS). During the MVV maneuver, participants were instructed to demonstrate in rapid and forceful inhalation and exhalation for a duration of 10 seconds. MVV will be reported in liter per minute (L/min). | Change from baseline MVV at 12 weeks. | |
Secondary | Respiratory muscle strength | Respiratory muscle strength was evaluated by measuring Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) in centimeters of water (cmH2O). The participants were seated and utilized a portable handheld mouth pressure meter (MicroRPM), along with a nose clip. To assess MIP, participants were instructed to exhale until they emptied their lungs at the point of functional residual capacity (FRC). Participants held the device to their mouth and forcefully inhaled for 1-2 seconds. For the measurement of MEP, participants were directed to inhale until their lungs were completely filled with air, starting from the total lung capacity (TLC) point. Participants were asked to maintain the device on their mouth and forcefully exhaled for 1-2 seconds. | Change from baseline respiratory muscle strength at 12 weeks. | |
Secondary | The Chair Sit and Reach Test | The Chair Sit and Reach Test is used to assess the flexibility of the back and legs. Participants sit in chairs with their feet touching the floor and positioned on the edge of the chair. The non-dominant leg should have the sole of the foot touching the floor, while the dominant foot is extended. Next, fold at the hips and reach with the middle finger of the hand on the same side as the outstretched leg to touch the middle finger to the outstretched foot. The researcher then measures the distance between the fingers and toes. If they touch each other, it indicates a distance equal to zero. Then, participants switch sides. | Change from baseline The Chair Sit and Reach Test scores at 12 weeks. | |
Secondary | The Back Scratch test | The Back Scratch test is conducted to assess shoulder flexibility. Participants perform stretches targeting their shoulders, shoulder blades, chest, and arms, then stand upright. They lift their right arm above the shoulder, bend the elbow down behind the back in a palm-down position, with palms and fingers resting flat on the back. Participants press down as far as possible. Simultaneously, they raise their left arm backward in an inward twisting motion, bending the elbow and folding it up so that the backs of their hands rest against the back of their body. They lift their hands as high as possible, trying to bring the right and left hands together as much as possible. After holding for about 3 seconds, participants return to the starting position with arms released at their sides. The test is repeated two more times on each side. The assessment measures the distance between the tip of the middle finger of the upper hand and the tip of the radial styloid process of the lower hand. | Change from baseline The Back Scratch test scores at 12 weeks. | |
Secondary | The Time Up and Go test | The Time Up and Go test is a mobility and balance assessment. Participants begin by sitting in chairs with the soles of both feet touching the floor. At the start of the test, participants stand up, walk towards a target 3 meters from the starting point, circumnavigate the target, and then return to their original seat. The researcher measures the time from the starting point until the participant returns to a seated position. | Change from baseline The Time Up and Go test time at 12 weeks. | |
Secondary | The Chair Stand test | The Chair Stand test involves the use of a chair without armrests. The chair should be tall enough for participants to sit with their feet touching the floor. Initially, participants are asked to sit in the chairs. When the test begins, they stand up with both hands holding the shoulder blades in a crossed position. A timer is then set for 30 seconds to count how many times participants can sit and stand within that duration. | Change from baseline The Chair Stand test scores at 12 weeks. | |
Secondary | The Arm Curl test | The Arm Curl test involves participants holding a steel ball on their dominant side, weighing 5 pounds for women and 8 pounds for men. Participants lift the steel ball with their arms fully bent and stretch their arms as far as possible, counting as one repetition. Participants perform as many repetitions as possible within a 30-second time frame. | Change from baseline The Arm Curl test scores at 12 weeks. | |
Secondary | The 2-Minute Step Test | The 2-Minute Step Test is an assessment of activity ability and endurance of the lower limb muscles. The researchers determined that the knee lift height for each elderly person would be at the midpoint between the knee and the upper edge of the hip bone. When the researcher gave the "start" command to the participants to raise their legs in place as many times as possible within 2 minutes, the researchers counted the number of leg lifts when the knees reached the designated point. | Change from baseline The 2-Minute Step Test scores at 12 weeks. | |
Secondary | The 6-Minute Walk Test | The 6-Minute Walk Test is a sub-maximal exercise test used to assess the ability to perform activities for extended periods. Participants are instructed by the researcher to walk at their comfortable speed for 6 minutes, covering a minimum distance of 15 meters before turning around. The researcher records the distance walked within the 6-minute timeframe. | Change from baseline The 6-Minute Walk Test scores at 12 weeks. | |
Secondary | Blood chemical data test | Draw 15 milliliters of blood to analyze blood biochemistry, including fasting plasma glucose (FPG), accumulated blood sugar level (HbA1c), insulin resistance (Homeostasis Model Assessment; HOMA-IR), cholesterol (Cholesterol), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (Triglyceride), BDNF (Brain-Derived Neurotrophic Factor), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-a). | Change from baseline blood chemical data at 12 weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |